Browsing by Author Mavroudis, D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 2 to 9 of 9 < previous 
TitleAuthor(s)Issue date???itemlist.???
'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancerPallis, A. G.; Voutsina, A.; Kalikaki, A.; Souglakos, J.; Briasoulis, E.; Murray, S.; Koutsopoulos, A.; Tripaki, M.; Stathopoulos, E.; Mavroudis, D.; Georgoulias, V.24-Nov-2015-
Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabinePappas, P.; Mavroudis, D.; Nikolaidou, M.; Georgoulias, V.; Marselos, M.24-Nov-2015-
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursBozionelou, V.; Vamvakas, L.; Pappas, P.; Agelaki, S.; Androulakis, N.; Kalykaki, A.; Nikolaidou, M.; Kentepozidis, N.; Giassas, S.; Marselos, M.; Georgoulias, V.; Mavroudis, D.24-Nov-2015-
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumorsKalbakis, K.; Pappas, P.; Kouroussis, C.; Vamvakas, L.; Kalykaki, A.; Vardakis, N.; Nikolaidou, M.; Marselos, M.; Georgoulias, V.; Mavroudis, D.24-Nov-2015-
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumorsSaridaki, Z.; Pappas, P.; Souglakos, J.; Nikolaidou, M.; Vardakis, N.; Kotsakis, A.; Marselos, M.; Georgoulias, V.; Mavroudis, D.24-Nov-2015-
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMavroudis, D.; Pappas, P.; Kouroussis, C.; Kakolyris, S.; Agelaki, S.; Kalbakis, K.; Androulakis, N.; Souglakos, J.; Vardakis, N.; Nikolaidou, M.; Samonis, G.; Marselos, M.; Georgoulias, V.24-Nov-2015-
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Pectasides, D.; Kalogera-Fountzila, A.; Skarlos, D.; Kalofonos, H. P.; Papadimitriou, C.; Bafaloukos, D.; Lambropoulos, S.; Papadopoulos, S.; Kourea, H.; Markopoulos, C.; Linardou, H.; Mavroudis, D.; Briasoulis, E.; Pavlidis, N.; Razis, E.; Kosmidis, P.; Gogas, H.24-Nov-2015-
PROGNOSTIC SIGNIFICANCE OF GENE EXPRESSION PROFILE IN PATIENTS WITH CARCINOMAS OF UNKNOWN PRIMARY (CAUP)Souglakos, J.; Pentheroudakis, G.; Papadaki, C.; Cervantes, A.; Petrakis, D.; Roodriguez-Braun, E.; Lagoudaki, E.; Georgoulias, V.; Mavroudis, D.; Pavlidis, N.24-Nov-2015-